Savara Inc. Announces New Inducement Awards for Employees Under 2021 Equity Incentive Plan
Savara Inc., a clinical stage biopharmaceutical company specializing in rare respiratory diseases, has announced the issuance of inducement awards to two newly hired employees. As of July 15, 2025, these awards include options to purchase a total of 20,000 shares of Savara's common stock, with an exercise price of $2.29 per share, and restricted stock units (RSUs) for an additional 20,000 shares. These awards are part of the Savara Inc. 2021 Inducement Equity Incentive Plan and are granted under NASDAQ Listing Rules. The stock options have a term of 10 years and vest quarterly over four years, while the RSUs will fully vest on the two-year anniversary of employment, contingent upon the employees' continued tenure with the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Savara Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250718610099) on July 18, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。